Risk classification
Separate clinical, patient-facing, and administrative uses, then set controls according to safety, privacy, and operational impact.
Healthcare AI compliance in Singapore
By Nuvexia Advisory Team
AI Governance Consulting
29/08/2026
Healthcare
Nuvexia helps healthcare organisations in Singapore govern AI used in clinical support, patient services, and administration. We align each use case with the PDPA, applicable health-sector and medical-device requirements, and ISO/IEC 42001, then define the evidence, human oversight, vendor checks, and monitoring needed for safe deployment.
Why healthcare AI needs its own controls
Health data is sensitive, clinical decisions can affect patient safety, and an incorrect output may look plausible to a busy user. That combination demands more than a generic acceptable-use policy.
The right control set depends on intended use. A scheduling assistant, a discharge-summary tool, and software that supports diagnosis do not carry the same risk. Teams should classify each system before choosing validation, approval, and monitoring requirements.
How Nuvexia helps
Health data governance
Map patient and operational data, access, transfers, retention, model inputs, generated outputs, and secondary uses.
Human oversight
Define when staff must review an output, when they may override it, and how uncertain or harmful results are escalated.
Vendor due diligence
Review product claims, validation evidence, data use, hosting, updates, incident duties, audit rights, and exit arrangements.
The governance baseline
A healthcare AI review should cover:
- Intended use, users, patient population, exclusions, and foreseeable misuse
- Personal data duties under Singapore's PDPA
- Clinical validation and performance across relevant patient groups
- Human review, overrides, escalation, and downtime procedures
- Security testing, access control, logging, and incident response
- Supplier responsibilities for updates, model changes, and disclosed limitations
- Post-deployment monitoring for performance drift and safety events
- Medical-device assessment where the software's intended purpose may bring it within Health Sciences Authority oversight
Applying ISO/IEC 42001
ISO/IEC 42001 can provide the management system around these controls. It helps an organisation assign responsibilities, assess AI risks and impacts, control documented information, monitor performance, run internal audits, and improve the programme.
The standard does not prove that a clinical model is safe or approved for a medical purpose. Clinical validation, professional accountability, licensing, and product regulation still need separate treatment.
Who this is for
- Hospitals, clinics, and healthcare networks deploying AI tools
- Healthtech and medtech companies building AI-enabled products
- Teams procuring AI for clinical documentation, triage, imaging support, operations, or patient communications
Frequently asked questions
What rules apply to AI in Singapore healthcare?
The PDPA applies to personal data. Depending on the system, providers may also need to address health-sector licensing, cybersecurity, clinical governance, records, and Health Sciences Authority medical-device requirements. The product and intended use determine the exact obligations.
Does ISO/IEC 42001 apply to healthcare AI?
Yes. It can structure governance, risk assessment, controls, monitoring, and improvement for both clinical and administrative AI. It does not replace healthcare law, product approval, or clinical validation.
How is clinical AI governance different from administrative AI governance?
Clinical AI may influence diagnosis, treatment, triage, or safety. It usually requires stronger validation, human oversight, escalation, change control, and monitoring than low-impact administrative automation.